DRT announces investments in two major product lines

By 9 September 2019October 15th, 2019No Comments

DRT is excited to announce that it has planned two large-scale investments in France, which will enable the company to facilitate the anticipated growth in key industry segments, and will further strengthen DRT’s global supply capabilities.

Increased production capacity for terpene resins

DRT will build a plant to produce terpene phenolic resins at its Lesperon site. The trade name of these products is Dertophene®. This will create a second production facility in France complementing our Vielle-Saint-Girons location. DRT’s total capacity for terpene phenolic resins will increase by more than 50% and will strategically be important for growth and contingencies.
Plant is scheduled to be completed by the end of 2020.

State of the art production unit for highly hydrogenated rosin

In Vielle-Saint-Girons, DRT will build a brand-new state of the art plant to produce hydrogenated rosin and resin derivatives. These products will have the highest degree of hydrogenation available in the market and are expected to meet current and future application requirements.
This investment will uniquely position DRT as a global supplier of hydrogenated rosin and resin derivatives, with dual production capabilities in France and the US. This additional capacity will enable DRT to meet the growing demand for sustainable raw materials in a variety of industry segments.
Plant is expected to be completed in the first half of 2021.